Price $11.96 |
Market Cap
468.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.05
|
P/S
-
|
Dividend %
-
|
|
P/CF
4.5
|
P/FCF
-
|
Op. Cash Flow
-27.8K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-29.40%
|
ROI
-21.40%
|
|
ROA
-24.30%
|
EPS Growth
-183.20%
|
Current Ratio
11.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $21.29 | - | - | 776.4M | Strong Buy |
| Harrow Health Inc (HROW) | $8.03 | - | - | 197.7M | Strong Buy |
| Boston Scientific Corporation (BSX) | $39.52 | - | - | 56.22B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $60.45 | - | 3.20% | 139.13B | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.11 | - | - | 959.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
